HoldsUp

Richard Johnson

University of Colorado School of Medicine

Richard Johnson is a professor of medicine at the University of Colorado School of Medicine. His research focuses on metabolic and renal health, with a particular emphasis on the physiological roles and health impacts of fructose and uric acid. His published work covers chronic kidney disease, podocyte injury, cardiovascular risk factors, and the effects of heat stress and diet on metabolic conditions.

34 claims checked on air: 4 context 4 overstated 25 supported 1 unverified

What they said on air

5 citing their own research

0:00:00supportedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Younger people with severe COVID-19 complications have a high frequency of obesity, and elevated uric acid may play a role in their increased risk.

"younger people, especially the younger people who have serious COVID-related complications, there's a high frequency of obesity in that group. And we think that one of the thoughts is that the uric acid may be playing a role in why they're at increased risk." (said at 0:00:00)

The speaker accurately states two related observations: obesity is a prominent risk factor for severe COVID-19 outcomes in younger demographics, and researchers have hypothesized that elevated uric acid (hyperuricemia)—which is strongly linked to obesity and metabolic syndrome—may contribute to the increased risk of severe COVID-19 complications and organ damage. Observational cohort data in hospitalized COVID-19 patients show that higher serum uric acid levels are independently associated with acute kidney injury, major adverse kidney events, and in-hospital mortality in a dose-dependent manner. Because the available evidence is observational and the causal role of uric acid remains hypothetical, the overall certainty of evidence is low.

0:04:43supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Only a small amount of dietary fructose enters the brain, but consumption of sugar, salt, and high-glycemic carbohydrates stimulates endogenous fructose production in the brain.

"when you eat fructose, only a small amount of fructose gets to the brain. So you would think that the brain would be safe from the effects of fructose to some extent. But what happens is the brain can actually make fructose. And when you eat sugar, we don't totally know the mechanism, but it seems that that stimulates fructose production in the brain. So sugar and salt and high-glycemic carbs all seem to drive fructose production in the brain." (said at 0:04:43)

Human and animal studies confirm that only minimal dietary fructose crosses the blood-brain barrier under physiological conditions, but the brain produces fructose endogenously from glucose via the polyol pathway (aldose reductase and sorbitol dehydrogenase). In humans undergoing hyperglycemic clamp experiments, intracerebral fructose increased significantly in response to elevated cerebral glucose. Mechanistic studies and reviews also demonstrate that high-glycemic loads and hyperosmolar stimuli (such as high salt) activate aldose reductase, driving endogenous fructose production in tissues including the hypothalamus.

0:08:55overstatedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Feeding animals fructose stimulates foraging behavior, hunger, and food searching while reducing deliberative thinking and willpower.

"when you feed animals fructose, they will start to forage, they'll look for food, they get hungry, they search, and they have to go into areas where it could be dangerous. And so the fructose actually works on the brain to try to decrease willpower, to block deliberative thinking, deliberation, and to kind of stimulate rapid responses and to be able to venture into areas where it might be dangerous." (said at 0:08:55)

The speaker describes the 'fructose survival hypothesis,' a theoretical framework primarily proposed in narrative and conceptual review papers by Johnson and colleagues. This model hypothesizes that fructose ingestion triggers an evolutionary survival pathway characterized by hunger, exploratory foraging behavior, impulsivity, and reduced executive deliberation to promote food acquisition. While animal and mechanistic studies demonstrate that fructose metabolism alters hypothalamic energy sensing (AMP depletion, uric acid generation) and stimulates food intake and risk-taking/foraging behaviors, presenting these neurocognitive concepts (such as directly 'blocking deliberative thinking' or 'decreasing willpower') as proven factual mechanisms in animals and humans overstates what remains a speculative evolutionary hypothesis supported only by very low-certainty preliminary evidence.

0:09:30needs contextmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

While most of the brain takes up glucose independently of insulin, glucose uptake in specific regions such as the hippocampus and hypothalamus requires insulin.

"the brain has certain areas that are insulin dependent and the brain has some areas that are not. So much of the brain does not require insulin for glucose uptake, but there's certain regions that do, and one of them is the hippocampus, the hypothalamus" (said at 0:09:30)

Most brain glucose uptake is mediated by the insulin-independent transporters GLUT1 (in endothelial cells and glia) and GLUT3 (in neurons). Certain brain regions, including the hippocampus, hypothalamus, and cerebellum, also express the insulin-sensitive glucose transporter GLUT4 and insulin receptors. In these regions, insulin stimulates GLUT4 translocation to increase glucose uptake and metabolic flux (e.g., during cognitive processing or metabolic regulation). However, basal glucose transport in the hippocampus and hypothalamus is still mediated by GLUT1 and GLUT3 and does not strictly require insulin for baseline survival or function.

0:10:00needs contextvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Fructose blocks insulin-mediated glucose uptake in the hippocampus, which impairs memory acutely and chronically leads to local insulin resistance, mitochondrial dysfunction, glycolysis, and inflammation.

"what fructose does is it blocks the effects of insulin to take up glucose in the hippocampus, and that kind of dampens the memory and allows the animal to feel that it can go into a dangerous area... And acutely that's okay because it makes you be able to forage, but chronically it results in basically an insulin resistance to this area where the cells are not getting enough fuel, there's mitochondrial dysfunction, a shift to glycolysis, which is a shift away from the mitochondria, the development of inflammation." (said at 0:10:00)

The speaker describes the 'fructose survival hypothesis' (developed primarily by Dr. Richard Johnson and colleagues), which posits that cerebral fructose metabolism evolved to promote foraging by transiently suppressing hippocampal metabolism and memory, while chronic overactivation causes local insulin resistance, mitochondrial dysfunction, a shift toward glycolysis, neuroinflammation, and cognitive impairment. While preclinical rodent studies and mechanistic reviews support these downstream pathological features (mitochondrial oxidative stress, hippocampal insulin signaling impairment, and neuroinflammation), the evolutionary framing regarding acute dampening of hippocampal function to promote risk-taking foraging remains a theoretical hypothesis rather than an established clinical fact in humans.

0:12:00supportedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

The enzyme AMP deaminase is elevated in the brains of patients with Alzheimer's disease.

"there's an enzyme that's turned on when fructose is metabolized, and we think it's the key enzyme that drives this survival switch, this energy shift, and it's called AMP deaminase. But that enzyme is elevated—AMP deaminase is high in the brains of patients with Alzheimer's." (said at 0:12:00)

Postmortem human brain tissue studies confirm that AMP deaminase enzymatic activity, protein, and mRNA expression are elevated in patients with Alzheimer's disease compared to age-matched controls (showing 1.6- to 2.4-fold increases across multiple examined brain regions). Because this evidence comes from small observational postmortem studies, certainty is rated as low.

0:17:00needs contextlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

A study from the University of Alabama by Dr. Singh showed that uric acid-lowering drugs like allopurinol protect against Alzheimer's disease in a dose-dependent manner.

"I think in your book you quote this beautiful study from the University of Alabama by Dr. Singh, where you point out that taking drugs that lower uric acid, like allopurinol, actually were found to protect against Alzheimer's. So having a low uric acid protects against Alzheimer's, and you actually pointed it out that the paper showed that the dose matters: the higher the dose of allopurinol, which lowers uric acid, was associated with more protection than others." (said at 0:17:00)

A 2018 observational Medicare cohort study led by Dr. Jasvinder A. Singh at the University of Alabama at Birmingham evaluated urate-lowering therapy and incident dementia. The study found that compared to low-dose allopurinol (<200 mg/day), higher allopurinol doses (200-299 mg/day and ≥300 mg/day) were associated with a dose-dependent decrease in the risk of incident dementia (HR 0.80 and 0.59, respectively). However, the study evaluated all-cause incident dementia using administrative billing codes rather than adjudicated Alzheimer's disease specifically, and its observational design demonstrates statistical association rather than proven causal protection.

0:20:05overstatedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Intracellular uric acid stimulates oxidative stress across virtually every cell type.

"when you put uric acid on cells and it goes into the cell, it stimulates oxidative stress. And it's been shown in just about every cell type. So when it's inside the cell, it causes oxidative stress and that is important in how it works." (said at 0:20:05)

In vitro and animal models demonstrate that soluble uric acid entering cells (via urate transporters) can stimulate intracellular oxidative stress and mitochondrial reactive oxygen species (ROS) production in several key cell types, including vascular endothelial cells, chondrocytes, hepatocytes, and renal cells. This pro-oxidant intracellular role contrasts with its well-known antioxidant function in plasma (often termed the 'uric acid paradox'). However, asserting that this has been shown in 'virtually every cell type' overstates preclinical in vitro literature, particularly as uric acid can exert protective antioxidant effects in other cellular contexts (such as certain neuronal models).

0:20:40supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Gout patients can develop uric acid crystal deposits in their blood vessels and kidneys in addition to their joints.

"Patients with gout have these crystals in their joints, but we're now discovering that they can get crystals in their blood vessels and in their kidneys and other sites." (said at 0:20:40)

Modern advanced imaging techniques—specifically dual-energy computed tomography (DECT)—as well as histopathological and autopsy studies have confirmed that patients with gout can develop monosodium urate (MSU) crystal deposits in extra-articular tissues beyond the joints. This includes the vasculature (e.g., coronary arteries, aorta, and peripheral vessels), the kidneys (interstitial MSU deposition and uric acid nephrolithiasis), and other anatomical sites (e.g., the spine, eyes, and skin).

0:21:00supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Elevated serum uric acid levels are associated with an increased risk of stroke.

"There are some studies in patients with stroke where it's been shown that if you have a high uric acid, you're at an increased risk for stroke, that's for sure." (said at 0:21:00)

Multiple systematic reviews and meta-analyses of prospective cohort studies confirm that elevated serum uric acid (SUA) levels are significantly associated with an increased risk of stroke, including both ischemic and hemorrhagic stroke.

0:21:12supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Extracellular uric acid reacts with certain radicals like peroxynitrite to remove them, but transiently generates peroxynitrite-like radicals in the process.

"uric acid does block some forms of oxidative stress, but it also can generate oxidative stress even extracellularly because when it reacts with certain radicals, it produces new radicals. And this is a problem of oxidants and antioxidants, and some of them can become a radical of themselves when they bind an oxidant. So they remove peroxynitrite, but they produce a peroxynitrite-like radical at least transiently." (said at 0:21:12)

The claim accurately reflects established biochemical findings regarding uric acid's dual antioxidant/pro-oxidant role. In vitro chemical studies demonstrate that uric acid scavenges peroxynitrite, but the reaction generates urate-derived free radicals (specifically identified as aminocarbonyl radicals and urate radicals), which can transiently propagate lipid peroxidation and other oxidative processes extracellularly.

0:22:00supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Clinical studies in Spain have investigated intravenous uric acid infusion acutely in stroke patients and suggested potential acute benefits.

"if you have a stroke, there's a group in—I believe the guy is in Spain, but he has done some studies where they've infused uric acid acutely in stroke, and they actually think that it might provide a little bit of benefit acutely." (said at 0:22:00)

The speaker's claim is supported by the URICO-ICTUS trial and its subsequent analyses, led by Dr. Angel Chamorro's group in Spain. In this randomized, double-blind, placebo-controlled phase 2b/3 trial, patients with acute ischemic stroke received an intravenous infusion of 1000 mg of uric acid (or placebo) during alteplase administration (PMID: 24703208). Although the primary outcome (excellent functional outcome at 90 days) did not reach statistical significance in the overall cohort (39% vs 33%, p=0.099), subsequent analyses suggested potential acute benefits, such as a reduction in early ischemic worsening (PMID: 27758945) and improved outcomes in patients who also underwent mechanical thrombectomy (PMID: 28345429).

0:23:43supportedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Mitochondrial oxidative stress induced by uric acid inhibits aconitase in the Krebs cycle, stimulating citrate accumulation, fat production, and insulin resistance while blocking beta-oxidation of fatty acids.

"when you create oxidative stress inside the cell, and especially in the mitochondria, the place where ATP is made, what the oxidative stress does is it works on the Krebs cycle to inhibit it. And it inhibits a specific enzyme called aconitase, and this enzyme is involved in the ATP production that's produced through the Krebs cycle. When it does that, it shifts—it causes a stimulation of citrate, which actually activates a pathway that leads to fat production. And so what happens is that oxidative stress is actually important in the stimulation of fat synthesis. So it stimulates the cell to produce fat, it also is involved in the insulin resistance that develops, and it also blocks the burning of fatty acids, what we call the beta fatty acid cycle." (said at 0:23:43)

The speaker's description matches the mechanism reported in published laboratory studies (mostly in cell cultures and animal models). Specifically, Lanaspa et al. (2012, PMID: 23035112) demonstrated that intracellular uric acid generates mitochondrial oxidative stress, which inhibits mitochondrial aconitase in the Krebs cycle. This causes accumulation and exportation of citrate to the cytosol, which activates lipogenic enzymes (such as ATP citrate lyase) leading to de novo fatty acid synthesis and insulin resistance/steatosis. Furthermore, studies on endothelial cells (Sanchez-Lozada et al., 2012, PMID: 23235493) confirmed uric acid-induced aconitase-2 activity reduction alongside decreased expression of enoyl-CoA hydratase-1 (an enzyme involved in beta-oxidation of fatty acids). Because the evidence for this specific biochemical sequence comes from preclinical cell culture and animal models, the grade of certainty is low.

0:27:45supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Initial fructose metabolism consumes intracellular ATP, causing intracellular phosphate and ATP levels to fall while suppressing AMP-activated protein kinase (AMPK) activation.

"initially when the fructose is first being metabolized, it burns a lot of ATP. So the ATP levels start to fall, and then when that intracellular phosphate level falls, then it stimulates the sweeping away of the AMP, which is normally regenerated to ATP. So it consumes the ATP, and then it prevents it from being regenerated because the AMP is swept away, and it also blocks an enzyme that helps produce the ATP called AMP-activated protein kinase." (said at 0:27:45)

The speaker accurately outlines the biochemical mechanism of early fructose metabolism. Rapid phosphorylation of fructose by fructokinase (ketohexokinase) consumes ATP and depletes intracellular phosphate and ATP pools. The decline in intracellular phosphate relieves allosteric inhibition of AMP deaminase, driving generated AMP into the purine degradation pathway (leading to uric acid synthesis) rather than allowing its recycling back into ATP or sustained canonical activation of AMP-activated protein kinase (AMPK).

0:30:35supportedhighThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Sugar, high-fructose corn syrup, and soft drinks are major risk factors for non-alcoholic fatty liver disease (NAFLD).

"But sugar and high-fructose corn syrup and soft drinks are a major risk factor for fatty liver, non-alcoholic fatty liver disease." (said at 0:30:35)

The claim is supported by extensive evidence from both observational meta-analyses and controlled clinical trials. A dose-response meta-analysis of observational studies (PMID: 31234281) demonstrated that sugar-sweetened beverage consumption is associated with a 39% overall increase in the odds of NAFLD in a dose-dependent manner (reaching a 53% increase with ≥7 cups/week). Furthermore, a meta-analysis of 51 controlled feeding trials (PMID: 35889803) showed with high GRADE certainty that adding excess calories from fructose-containing sugar-sweetened beverages directly increases intrahepatocellular lipid (liver fat) accumulation.

0:31:55supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Non-alcoholic fatty liver disease and alcoholic liver disease share biochemical abnormalities including low AMP, high oxidative stress, and elevated uric acid.

"And the two have some of the same biochemical problems, like AMP is low in both, oxidative stress is high in both, uric acid is high in both, and so forth." (said at 0:31:55)

Published human, animal, and mechanistic literature confirms that non-alcoholic fatty liver disease (NAFLD/MASLD) and alcohol-associated liver disease (ALD) share key biochemical pathways. Both fructose/nutrient overload in NAFLD and ethanol metabolism in ALD drive nucleotide turnover (via AMP deaminase activation leading to transient depletion of cellular ATP/AMP and rapid purine degradation), elevated uric acid generation, and increased oxidative stress and reactive oxygen species.

0:32:55supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Co-administering fructose or sugar with alcohol accelerates alcohol metabolism and increases voluntary alcohol intake in animal models.

"And it's also known that when you give alcohol and sugar together, that the sugar or fructose makes the alcohol more powerful, it accelerates alcohol metabolism, and the two work together. And like if we give an animal alcohol and we give it sugar, it will increase its alcohol intake, and not only that, it will—they will get much more dramatic liver disease." (said at 0:32:55)

Co-administration of fructose or carbohydrate solutions with ethanol accelerates alcohol metabolism and clearance from the bloodstream (often referred to as the 'fructose effect'), demonstrated in both animal models and clinical human trials.

0:33:25supportedlowtheir own paperThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Alcohol consumption activates an enzyme that converts glucose to fructose, causing endogenous fructose synthesis in the liver.

"when you drink alcohol, the alcohol activates an enzyme to make fructose in the body. It's not the alcohol becoming fructose. The alcohol is alcohol, but the alcohol affects an enzyme that's normally not active and it gets turned on by alcohol, and this enzyme converts glucose to fructose and you start making fructose." (said at 0:33:25)

The speaker accurately describes the activation of the polyol pathway by alcohol. Research in human liver specimens and animal models shows that ethanol consumption upregulates aldose reductase (AR), the rate-limiting enzyme of the polyol pathway that converts glucose to sorbitol (which is subsequently converted to fructose). This pathway leads to endogenous fructose generation in the liver and contributes to alcohol-induced metabolic dysfunction and liver injury.

0:34:26supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

A human study showed that aldose reductase is activated and fructose is present in the liver of individuals drinking alcohol.

"And so this group from Kentucky actually did a beautiful study in humans and showed that this enzyme is turned on in the liver of people drinking alcohol and that there's fructose in the liver of people drinking alcohol." (said at 0:34:26)

A 2020 study by researchers investigating alcohol-associated liver disease examined human liver specimens from patients with alcoholic hepatitis (alongside experimental animal models) and demonstrated significant upregulation of aldose reductase (AR) as well as elevated levels of its downstream metabolites, including sorbitol and fructose, in the liver.

0:34:56supportedvery lowtheir own paperThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

In animal models, blocking fructose metabolism or blocking aldose reductase prevents alcohol-induced fatty liver disease.

"when we blocked fructose metabolism, we could block the fatty liver that was induced by alcohol. ... There was a group in China that blocked the enzyme that converts glucose to fructose, and they could block alcoholic liver disease that way in animals too." (said at 0:34:56)

The speaker's statement is supported by animal studies. In mouse models of alcohol-associated liver disease (ALD), genetic knockout of ketohexokinase (KHK-A/C, which blocks fructose metabolism) protects mice against alcohol-induced hepatic steatosis, inflammation, and fibrosis. Similarly, genetic deletion or pharmacological inhibition of aldose reductase (the rate-limiting enzyme of the polyol pathway converting glucose to sorbitol/fructose) prevents alcohol-induced hepatic steatosis and liver injury in rodents. Because the evidence for this specific claim is derived entirely from animal and cell culture models, certainty is rated as very low.

0:38:04supportedhightheir own paperThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

The polyol pathway via aldose reductase is the only enzymatic pathway by which the body synthesizes endogenous fructose.

"and there's only one way the body makes fructose, only one, and it's through this enzyme called aldose reductase, or what I call the polyol pathway." (said at 0:38:04)

The speaker's statement is biochemically accurate. In mammalian biochemistry, the polyol pathway (in which aldose reductase converts glucose to sorbitol, followed by sorbitol dehydrogenase converting sorbitol to fructose) is the only known enzymatic pathway for the endogenous synthesis of fructose from glucose.

0:38:35supportedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Reduced blood flow during a heart attack stimulates local fructose synthesis in the heart via aldose reductase.

"So it gets turned on, for example, like if you have a heart attack, when the blood flow is low to the heart, that will stimulate local production of fructose in the heart." (said at 0:38:35)

The speaker accurately describes the activation of the polyol pathway during myocardial ischemia. Under conditions of reduced blood flow (such as during a myocardial infarction or cardiac ischemia), flux through aldose reductase is stimulated, initiating the two-step polyol pathway where glucose is reduced to sorbitol by aldose reductase and subsequently oxidized to fructose by sorbitol dehydrogenase. Evidence for this local cardiac pathway activation and its contribution to ischemic injury comes primarily from animal models and preclinical tissue studies.

0:39:37supportedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Elevated uric acid levels directly stimulate and activate aldose reductase, driving further endogenous fructose production.

"When uric acid goes up, it activates aldose reductase. So uric acid is one of the—in fact, we have thought that although uric acid causes this oxidative stress and all these things that are bad, we have considered the possibility that this feedback loop to stimulate aldose reductase may be one of the stronger mechanisms by which uric acid is causing its problems." (said at 0:39:37)

Preclinical in vitro and animal studies demonstrate that uric acid upregulates aldose reductase expression (via oxidative stress and NFAT5 activation), leading to increased endogenous fructose synthesis and establishing a positive feedback loop. Evidence to date is limited to cell culture and rodent models, so certainty is very low.

0:43:24supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Obstructive sleep apnea is strongly associated with gout and obesity.

"Obstructive sleep apnea is super associated with gout, it's really associated with obesity." (said at 0:43:24)

Obstructive sleep apnea (OSA) is robustly associated with both gout (and elevated serum uric acid) and obesity. Systematic reviews and meta-analyses show that patients with OSA have a significantly increased risk of developing gout (RR ~1.29) and higher serum uric acid levels, which improve with CPAP therapy. Furthermore, obesity is one of the strongest established risk factors for OSA, with individuals with obesity having nearly a 5-fold higher odds of having OSA compared to normal-weight individuals (OR 4.84).

0:44:48supportedhighThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Obesity is associated with an increased risk for breast cancer, pancreatic cancer, and colon cancer.

"people with obesity have an increased risk for breast cancer and pancreatic cancer and colon cancer." (said at 0:44:48)

A landmark umbrella review of systematic reviews and meta-analyses (Kyrgiou et al., 2017, BMJ) evaluated the evidence across 36 cancer sites and found that adiposity/obesity is supported by strong epidemiological evidence as a risk factor for colon cancer, pancreatic cancer, and postmenopausal breast cancer.

0:46:20overstatedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Research by Lewis Cantley and others indicates that cancer cells prefer fructose over other fuels, specifically in liver cancer and colon cancer.

"And so some beautiful work by Lewis Cantley and others have shown that high-fructose corn syrup and fructose are fuels for cancer cells, and a lot of cancer cells prefer fructose over other fuels, so liver cancer and colon cancer." (said at 0:46:20)

While research by Lewis Cantley and colleagues (such as Goncalves et al., 2019 and Taylor et al., 2021) demonstrates that high-fructose corn syrup (HFCS) and fructose can act as fuels that promote intestinal (colon) tumor growth, the claim that cancer cells 'prefer fructose over other fuels' is an overstatement. Most cancer cells, including colorectal and liver cancers, primarily rely on glucose as their main energy source (the Warburg effect). Cantley's research showed that fructose is metabolized alongside glucose, acting synergistically to accelerate glycolysis and fatty acid synthesis, rather than being preferred over glucose. Additionally, these landmark studies were conducted in mouse models, meaning direct translation to human cancer fuel preferences remains preliminary.

0:47:20supportedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

In mice lacking functional uricase or with uricase inhibited, cancers metastasize much faster in the presence of high uric acid.

"So we took mice and we knocked out their uricase or we inhibited it in both ways, and when we give them a cancer, it metastasizes much, much faster in the setting of a high uric acid and an absence of uricase." (said at 0:47:20)

The speaker's description matches published experimental findings in rodent models. A 2021 study evaluated breast cancer cell progression in mice with uricase inactivated either genetically (uricase knockout) or pharmacologically (inhibition with oxonic acid), as well as in uricase-transgenic mice. The authors found that loss or inhibition of uricase (which leads to elevated uric acid levels) was associated with a substantial increase in tumor growth and metastases, whereas transgenic uricase expression reduced tumor growth. Because the supporting evidence comes strictly from animal models, the GRADE certainty is very low.

0:50:45needs contextmoderatetheir own paperThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

When blood glucose levels rise above 120 mg/dL, the polyol pathway begins converting glucose into fructose.

"when your glucose levels start going up over 120, you start making fructose from it, and you're also stimulating insulin." (said at 0:50:45)

The speaker accurately describes the biochemical mechanism whereby elevated blood glucose increases flux through the polyol pathway (via aldose reductase and sorbitol dehydrogenase) to produce endogenous fructose, which concurrently stimulates insulin secretion. However, describing this as an on/off switch occurring specifically when glucose exceeds 120 mg/dL simplifies a continuous biochemical concentration gradient. Aldose reductase has a relatively high Km (low affinity) for glucose compared to hexokinase; consequently, polyol pathway flux increases progressively across rising postprandial or hyperglycemic glucose concentrations rather than abruptly activating at a strict threshold of 120 mg/dL.

0:56:00unverifiedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Placing a human subject on a high-salt diet can induce insulin resistance within one week.

"if you put a person on a high-salt diet, you can induce insulin resistance fairly quickly, like even within a week." (said at 0:56:00)

No matching published clinical trial or study record evaluating the induction of insulin resistance within one week of a high-salt diet in humans was successfully retrieved within the search query limits. This does not prove the claim false, but means it could not be independently confirmed against the indexed literature during this search.

0:57:25supportedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

In animal experiments, high-salt intake leads to obesity and diabetes through endogenous fructose production, and blocking fructose metabolism prevents this high-salt-induced obesity.

"We put them on salt, you know, there's not much going on for the first two or three months, and then suddenly a little bit later on they start getting fat, and then they get really fat, and they become enormously fat and diabetic. And we can show that it was due to this production of fructose, because if we block their ability to metabolize fructose, even though they're not getting any in their diet, we can block obesity." (said at 0:57:25)

The speaker's claim accurately describes findings published in PNAS (Lanaspa et al., 2018). In mice, high-salt intake triggered endogenous fructose production and metabolism via the aldose reductase–fructokinase pathway, driving hyperphagia, leptin resistance, obesity, and insulin resistance/diabetes. Blocking fructose metabolism (via fructokinase knockout) protected the animals from high-salt-induced obesity. Because this evidence is derived from preclinical animal models, the GRADE certainty is very low for direct application to humans.

0:59:34supportedmoderateThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Circulating vasopressin, measured via copeptin, is elevated in people with obesity.

"And we actually know that people who are overweight have high vasopressin levels in their blood, and it's the test that's usually measured is called copeptin, but it's a it's like it's a stable measurement of vasopressin and it's high in people with obesity." (said at 0:59:34)

Large population-based observational cohort studies and clinical reviews confirm that copeptin—a stable surrogate marker reflecting circulating arginine vasopressin (AVP) secretion—is significantly elevated in individuals with overweight and obesity, and correlates positively with BMI, waist circumference, and the risk of developing abdominal obesity.

0:59:50supportedvery lowtheir own paperThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Dietary consumption of either sugar or salt increases circulating levels of vasopressin in animals.

"and when we were giving sugar to animals as well as salt to animals, we found that vasopressin levels went up in the blood." (said at 0:59:50)

Animal experimental studies demonstrate that oral administration of sugars (fructose, glucose, high-fructose corn syrup) as well as salt increases circulating levels of vasopressin (measured directly or via its surrogate biomarker copeptin) in rodent models. Because the claim specifically describes animal experimental findings, the available pre-clinical literature directly supports the statement.

1:00:10supportedvery lowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

Vasopressin acts through the V1b receptor to mediate obesity and the metabolic effects of sugar, and blocking the V1b receptor blocks these effects in animals.

"and it's the vasopressin is blocking or is binding to this V1b receptor, and that is important in how obesity occurs, because when you block that receptor, you can block sugar effects." (said at 1:00:10)

Animal research directly supports the claim that vasopressin promotes sugar (fructose)-induced metabolic syndrome and fat accumulation through the V1b receptor. In murine models, deletion or knocking out of the V1b receptor (V1bR-KO) completely protected mice against fructose-induced metabolic syndrome and obesity, whereas activating this pathway enhanced fructokinase expression. Because the supporting evidence comes strictly from preclinical animal knockout models, the GRADE certainty is very low.

1:04:07overstatedlowThe Dangers of Fructose & Uric Acid - with Dr. Richard Johns

High-glycemic carbohydrates and wheat are associated with dementia and neurobehavioral disorders.

"this whole relationship of of grains and, I mean, of wheat and and high-glycemic carbs and their relationship to dementia and to all these neurobehavioral issues" (said at 1:04:07)

Large prospective cohort studies (such as the UK Biobank and the French Three-City study) show that high glycemic load (GL) diets and refined carbohydrates are associated with an increased risk of dementia, Alzheimer's disease, and cognitive decline, particularly in APOE-ε4 carriers. However, attributing broad neurobehavioral issues and dementia risk specifically to wheat itself in the general population is overstated and unsupported by clinical evidence, outside of specific gluten-related pathologies (such as celiac disease or gluten ataxia).

Fact-checked episodes

Publications